457 related articles for article (PubMed ID: 35615979)
1. Knee osteoarthritis and the knowledgeable, trustworthy pharmacist: Patient and pharmacist perceptions of community pharmacy-based education and support.
Darlow B; Brown M; Hudson B; Frew G; Clark J; Vincent L; Grainger R; Marra C; McKinlay E; Abbott JH; Briggs AM
Musculoskeletal Care; 2023 Mar; 21(1):3-15. PubMed ID: 35615979
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist health coaching in Australian community pharmacies: What do pharmacy professionals think?
Singh HK; Kennedy GA; Stupans I
Health Soc Care Community; 2020 Jul; 28(4):1190-1198. PubMed ID: 32020737
[TBL] [Abstract][Full Text] [Related]
3. Pharmacist peer coaching in a traditional community chain pharmacy: Implementation and perceptions.
Hake KL; Carroll JC; Somma McGivney MA; Coley KC
J Am Pharm Assoc (2003); 2021; 61(4S):S85-S90. PubMed ID: 33781696
[TBL] [Abstract][Full Text] [Related]
4. Qualitative exploration of the experiences of community pharmacists delivering the Diabetes MedsCheck service.
Gargya D; Mirkazemi C; Curtain C
J Clin Pharm Ther; 2022 Aug; 47(8):1194-1200. PubMed ID: 35322454
[TBL] [Abstract][Full Text] [Related]
5. Examining the association between the "My Pharmacist" model and the service quality of community pharmacies.
Goto K; Sato T; Shikamura Y; Nomura K; Negishi K; Hanawa T
Res Social Adm Pharm; 2020 Jul; 16(7):958-966. PubMed ID: 31839583
[TBL] [Abstract][Full Text] [Related]
6. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
Puspitasari HP; Aslani P; Krass I
Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
[TBL] [Abstract][Full Text] [Related]
7. Management of hypertension in an Australian community pharmacy setting - patients' beliefs and perspectives.
Bajorek BV; LeMay KS; Magin PJ; Roberts C; Krass I; Armour CL
Int J Pharm Pract; 2017 Aug; 25(4):263-273. PubMed ID: 27633151
[TBL] [Abstract][Full Text] [Related]
8. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates.
Alzubaidi H; Saidawi W; Mc Namara K
Int J Clin Pharm; 2018 Oct; 40(5):1106-1115. PubMed ID: 29926256
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist and physician perspectives on diabetes service delivery within community pharmacies in Indonesia: a qualitative study.
Wibowo Y; Sunderland B; Hughes J
Int J Pharm Pract; 2016 May; 24(3):180-8. PubMed ID: 26670327
[TBL] [Abstract][Full Text] [Related]
10. Implementation of comprehensive medication management at supermarket pharmacies in a pharmacy network.
Doong K; Berenbrok LA; Coley KC; Carroll JC; Richardson R; Antinopoulos BC; Patel A; McGivney MS
J Am Pharm Assoc (2003); 2019; 59(4S):S25-S31. PubMed ID: 31080149
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing patient participation in medication counseling at the community pharmacy: A systematic review.
Qudah B; Thakur T; Chewning B
Res Social Adm Pharm; 2021 Nov; 17(11):1863-1876. PubMed ID: 33766505
[TBL] [Abstract][Full Text] [Related]
12. Perspectives on an amended law addressing pharmacists' availability in community pharmacies.
Qadeer G; Amin MEK
J Eval Clin Pract; 2021 Feb; 27(1):151-157. PubMed ID: 32319720
[TBL] [Abstract][Full Text] [Related]
13. Successful implementation and provision of enhanced and extended pharmacy services.
Hattingh L; Sim TF; Sunderland B; Czarniak P
Res Social Adm Pharm; 2020 Apr; 16(4):464-474. PubMed ID: 31272922
[TBL] [Abstract][Full Text] [Related]
14. Patient and prescriber perceptions of depression screening within a community pharmacy setting.
Mospan CM; Gillette C; Wilson JA
J Am Pharm Assoc (2003); 2020; 60(5S):S15-S22. PubMed ID: 32280022
[TBL] [Abstract][Full Text] [Related]
15. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacists' perceptions of services that benefit older people in New Zealand.
Tordoff J; Chang SY; Norris PT
Int J Clin Pharm; 2012 Apr; 34(2):342-50. PubMed ID: 22328011
[TBL] [Abstract][Full Text] [Related]
17. Pharmacists experience of and perspectives about recruiting patients into a community pharmacy asthma service trial.
Bertilsson E; Serhal S; Emmerton L; Bosnic-Anticevich S; Krass I; Bereznicki B; Bereznicki L; Armour C; Saini B
Res Social Adm Pharm; 2021 Mar; 17(3):595-605. PubMed ID: 32448767
[TBL] [Abstract][Full Text] [Related]
18. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
19. Enablers and challenges to pharmacy practice change in Kuwait hospitals: a qualitative exploration of pharmacists' perceptions.
Katoue MG
J Eval Clin Pract; 2021 Apr; 27(2):272-279. PubMed ID: 32929812
[TBL] [Abstract][Full Text] [Related]
20. Community pharmacist-led clinical services: physician's understanding, perceptions and readiness to collaborate in a Midwestern state in the United States.
Gordon C; Unni E; Montuoro J; Ogborn DB
Int J Pharm Pract; 2018 Oct; 26(5):407-413. PubMed ID: 29218803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
